Magalasin, Rolando B.
HRN: 24-66-67 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/20/2024
CEFIXIME 200MG (CAP)
03/20/2024
03/26/2024
PO
200mg
BID
Infected Wound Left Upper Back
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes